These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 22578371)

  • 41. Perioperative hemostatic management of patients treated with vitamin K antagonists.
    Levy JH; Tanaka KA; Dietrich W
    Anesthesiology; 2008 Nov; 109(5):918-26. PubMed ID: 18946305
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Emergency reversal of vitamin-K antagonists related over-anticoagulation: case report and brief overview on the role of prothrombin complex concentrate.
    Di Fusco SA; Aspromonte N; Aquilani S; Mele L; Colivicchi F
    Monaldi Arch Chest Dis; 2013 Dec; 80(4):184-8. PubMed ID: 25087295
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Study of Octaplex dosing accuracy: an in vitro analysis.
    Patriquin CJ; Chin-Yee IH; Kovacs MJ; Lazo-Langner A; Keeney M; Hsia CC
    Thromb Haemost; 2012 Feb; 107(2):248-52. PubMed ID: 22186847
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Practical treatment of warfarin associated coagulation disorder].
    Garcia D; Crowther MA; Ageno W
    Praxis (Bern 1994); 2010 Dec; 99(25):1569-73. PubMed ID: 21157725
    [No Abstract]   [Full Text] [Related]  

  • 45. Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors.
    Kaatz S; Kouides PA; Garcia DA; Spyropolous AC; Crowther M; Douketis JD; Chan AK; James A; Moll S; Ortel TL; Van Cott EM; Ansell J
    Am J Hematol; 2012 May; 87 Suppl 1():S141-5. PubMed ID: 22473649
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Reversal of oral anticoagulation in intracranial hemorrhage].
    Bösel J; Steiner T
    Dtsch Med Wochenschr; 2010 Nov; 135(47):2366-9. PubMed ID: 21082529
    [No Abstract]   [Full Text] [Related]  

  • 47. Comparison of the efficacy and safety profiles of intravenous vitamin K and fresh frozen plasma as treatment of warfarin-related over-anticoagulation in patients with mechanical heart valves.
    Yiu KH; Siu CW; Jim MH; Tse HF; Fan K; Chau MC; Chow WH
    Am J Cardiol; 2006 Feb; 97(3):409-11. PubMed ID: 16442406
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Warfarin-reversal: results of a phase III study with pasteurised, nanofiltrated prothrombin complex concentrate.
    Pabinger-Fasching I
    Thromb Res; 2008; 122 Suppl 2():S19-22. PubMed ID: 18549908
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prothrombin complex concentrates used alone in urgent reversal of warfarin anticoagulation.
    Tran H; Collecutt M; Whitehead S; Salem HH
    Intern Med J; 2011 Apr; 41(4):337-43. PubMed ID: 20403070
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reversal of warfarin anticoagulation for urgent surgical procedures.
    Curtis R; Schweitzer A; van Vlymen J
    Can J Anaesth; 2015 Jun; 62(6):634-49. PubMed ID: 25846343
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevention of treatment-related fluid overload reduces estimated effective cost of prothrombin complex concentrate in patients requiring rapid vitamin K antagonist reversal.
    Jones CA; Ducis K; Petrozzino J; Clark E; Fung MK; Peters C; Sarkar IN; Krol E; Pochal B; Boutrus A; Weimersheimer P; Freeman K
    Expert Rev Pharmacoecon Outcomes Res; 2016; 16(1):135-9. PubMed ID: 26211539
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Low-dose oral vitamin K reliably reverses over-anticoagulation due to warfarin.
    Crowther MA; Donovan D; Harrison L; McGinnis J; Ginsberg J
    Thromb Haemost; 1998 Jun; 79(6):1116-8. PubMed ID: 9657434
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Warfarin reversal with prothrombin complex concentrate confers better antifibrinolytic activity compared with recombinant activated factor VII.
    Taketomi T; Szlam F; Levy JH; Tanaka KA
    Blood Coagul Fibrinolysis; 2008 Jan; 19(1):106-8. PubMed ID: 18180627
    [No Abstract]   [Full Text] [Related]  

  • 54. Contemporary Anticoagulation Reversal Focus on Direct Thrombin Inhibitors and Factor Xa Inhibitors.
    Mancl EE; Crawford AN; Voils SA
    J Pharm Pract; 2013 Feb; 26(1):43-51. PubMed ID: 23160865
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The use of prothrombin complex concentrate as a warfarin reversal agent in pediatric patients undergoing orthotopic heart transplantation.
    Sisti DJ; Williams GD; Ding V; Long J; Maeda K; Chen S; Navaratnam M
    Paediatr Anaesth; 2020 May; 30(5):564-570. PubMed ID: 32037665
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prothrombin complex concentrate (Octaplex) in patients requiring immediate reversal of oral anticoagulation.
    Riess HB; Meier-Hellmann A; Motsch J; Elias M; Kursten FW; Dempfle CE
    Thromb Res; 2007; 121(1):9-16. PubMed ID: 17407788
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anticoagulant management in the cardiovascular setting.
    Verheugt FW
    Fundam Clin Pharmacol; 2012 Feb; 26(1):11-5. PubMed ID: 21831129
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Coagulopathy reversal in intracerebral haemorrhage.
    Sweidan AJ; Singh NK; Conovaloff JL; Bower M; Groysman LI; Shafie M; Yu W
    Stroke Vasc Neurol; 2020; 5(1):29-33. PubMed ID: 32411405
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prothrombin complex concentrate for oral anticoagulant reversal in neurosurgical emergencies.
    Cartmill M; Dolan G; Byrne JL; Byrne PO
    Br J Neurosurg; 2000 Oct; 14(5):458-61. PubMed ID: 11198768
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Retrospective evaluation of a method to predict fresh-frozen plasma dosage in anticoagulated patients.
    Frazee LA; Bourguet CC; Gutierrez W; Elder-Arrington J; Elackattu AE; Haller NA
    Am J Ther; 2008; 15(2):111-8. PubMed ID: 18356630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.